GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avenir Wellness Solutions Inc (OTCPK:AVRW) » Definitions » Beneish M-Score
中文

Avenir Wellness Solutions (Avenir Wellness Solutions) Beneish M-Score : -7.87 (As of Apr. 25, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Avenir Wellness Solutions Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -7.87 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Avenir Wellness Solutions's Beneish M-Score or its related term are showing as below:

AVRW' s Beneish M-Score Range Over the Past 10 Years
Min: -92.9   Med: -3   Max: 26.84
Current: -7.87

During the past 8 years, the highest Beneish M-Score of Avenir Wellness Solutions was 26.84. The lowest was -92.90. And the median was -3.00.


Avenir Wellness Solutions Beneish M-Score Historical Data

The historical data trend for Avenir Wellness Solutions's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avenir Wellness Solutions Beneish M-Score Chart

Avenir Wellness Solutions Annual Data
Trend Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beneish M-Score
Get a 7-Day Free Trial -8.01 -2.91 -1.21 -2.79 -0.71

Avenir Wellness Solutions Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.20 -0.71 -4.26 0.33 -7.87

Competitive Comparison of Avenir Wellness Solutions's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Avenir Wellness Solutions's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avenir Wellness Solutions's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avenir Wellness Solutions's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Avenir Wellness Solutions's Beneish M-Score falls into.



Avenir Wellness Solutions Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Avenir Wellness Solutions for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.7031+0.528 * 1.2561+0.404 * 0.6212+0.892 * 0.7689+0.115 * 1.2144
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1235+4.679 * -0.802198-0.327 * 4.4817
=-7.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep23) TTM:Last Year (Sep22) TTM:
Total Receivables was $1.44 Mil.
Revenue was 1.015 + 0.972 + 1.238 + 0.913 = $4.14 Mil.
Gross Profit was 0.737 + 0.694 + 0.977 + 0.199 = $2.61 Mil.
Total Current Assets was $1.98 Mil.
Total Assets was $2.82 Mil.
Property, Plant and Equipment(Net PPE) was $0.08 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.25 Mil.
Selling, General, & Admin. Expense(SGA) was $8.17 Mil.
Total Current Liabilities was $12.79 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Net Income was -2.224 + -0.987 + -0.209 + -7.146 = $-10.57 Mil.
Non Operating Income was -0.666 + 0.859 + 1.428 + -5.019 = $-3.40 Mil.
Cash Flow from Operations was -0.721 + -1.193 + -1.405 + -1.586 = $-4.91 Mil.
Total Receivables was $2.66 Mil.
Revenue was 1.784 + 1.123 + 1.076 + 1.399 = $5.38 Mil.
Gross Profit was 1.428 + 0.973 + 0.739 + 1.119 = $4.26 Mil.
Total Current Assets was $8.25 Mil.
Total Assets was $14.96 Mil.
Property, Plant and Equipment(Net PPE) was $0.19 Mil.
Depreciation, Depletion and Amortization(DDA) was $2.07 Mil.
Selling, General, & Admin. Expense(SGA) was $9.46 Mil.
Total Current Liabilities was $15.06 Mil.
Long-Term Debt & Capital Lease Obligation was $0.08 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1.438 / 4.138) / (2.66 / 5.382)
=0.347511 / 0.49424
=0.7031

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4.259 / 5.382) / (2.607 / 4.138)
=0.791342 / 0.630014
=1.2561

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1.976 + 0.081) / 2.821) / (1 - (8.251 + 0.189) / 14.964)
=0.270826 / 0.43598
=0.6212

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4.138 / 5.382
=0.7689

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2.07 / (2.07 + 0.189)) / (0.249 / (0.249 + 0.081))
=0.916335 / 0.754545
=1.2144

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(8.169 / 4.138) / (9.457 / 5.382)
=1.974142 / 1.757153
=1.1235

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 12.789) / 2.821) / ((0.081 + 15.056) / 14.964)
=4.533499 / 1.011561
=4.4817

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-10.566 - -3.398 - -4.905) / 2.821
=-0.802198

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Avenir Wellness Solutions has a M-score of -7.87 suggests that the company is unlikely to be a manipulator.


Avenir Wellness Solutions Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Avenir Wellness Solutions's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Avenir Wellness Solutions (Avenir Wellness Solutions) Business Description

Traded in Other Exchanges
N/A
Address
5805 Sepulveda Boulevard, Suite 801, Sherman Oaks, CA, USA, 91411
Avenir Wellness Solutions Inc is a broad wellness platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on approximately 15 current patents, offers several immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The company sells its product under the brand names Seratopical, Seratopical Revolution, SeraLabs, and Nutri-Strips.
Executives
Robert J Costantino director 5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Joel M Bennett officer: CFO,CAO, Treasurer & Secretary 22619 PACIFIC COAST HIGHWAY, MALIBU CA 90265
Gerald Bagg director C/O CURE PHARMACEUTICAL HOLDING CORP., 5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Nancy Duitch officer: Chief Strat Officer-Wellness 15950 ROYAL OAK RD, ENCINO CA 91436
Robert Steven Davidson director, officer: CEO & Director 5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Jonathan Berlent officer: Chief Business Officer 1620 BEACON PLACE, OXNARD CA 93033
John K Bell director 38 FALLBROOK LANE RR 33, CAMBRIDGE A6 N3H 4R8
Anna Goldin director 1620 BEACON STREET, OXNARD CA 93033
Lauren Chung director 1620 BEACON STREET, OXNARD CA 93033
Michael Redard officer: Chief Financial Officer 1620 BEACON PLACE, OXNARD CA 93033
Joshua Held director 1620 BEACON PLACE, OXNARD CA 93033
Climate Change Investigation, Innovation & Investment Company, Llc 10 percent owner 12 SAN RAFAEL AVE, BELVEDERE CA 94920
Ruben Jr King-shaw director 1620 BEACON PLACE, OXNARD CA 93033
Gene Z Salkind director 5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Alex Katz officer: CFO 1233 FAIRY HILL ROAD, RYDAL PA 19046

Avenir Wellness Solutions (Avenir Wellness Solutions) Headlines

From GuruFocus

CURE Pharmaceutical Letter to Shareholders

By ACCESSWIRE ACCESSWIRE 12-15-2022